...A. Based on the proxies received, the Inspector has reported to me that a majority of the 381,688,836 shares of common stock entitled to vote are represented at the meeting either in person or by proxy. B. This approval will increase the number of shares available for issuance pursuant to awards made under the plan and will also extend the duration of the plan from April 30, 2027, to May 8, 2035. C. This approval will increase the number of shares of common stock that may be issued under the plan, and will also extend the terms to permit awards to be made with respect to performance for any year through 2034. D. This approval will increase the number of shares that may be issued under the plan, and will also permit new purchase periods to be designated through May 8, 2035. E. And after crossing $20 billion of sales in 2023, we are now moving towards $30 billion, with another year of double-digit organic sales growth in 2024. F. 2024 was an active year on the acquisition front, as we completed...